Novolog Pharm-Up 1966 Ltd
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Health Services, and Digital. The Logistics division engages in the import and distribution of pharmaceuticals and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation proces… Read more
Novolog Pharm-Up 1966 Ltd (NVLG) - Total Assets
Latest total assets as of September 2025: ILA3.06 Billion ILA
Based on the latest financial reports, Novolog Pharm-Up 1966 Ltd (NVLG) holds total assets worth ILA3.06 Billion ILA as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Novolog Pharm-Up 1966 Ltd - Total Assets Trend (2014–2024)
This chart illustrates how Novolog Pharm-Up 1966 Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Novolog Pharm-Up 1966 Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Novolog Pharm-Up 1966 Ltd's total assets of ILA3.06 Billion consist of 78.0% current assets and 22.0% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 8.2% |
| Accounts Receivable | ILA1.76 Billion | 57.9% |
| Inventory | ILA315.07 Million | 10.4% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA159.25 Million | 5.2% |
| Goodwill | ILA156.20 Million | 5.1% |
Asset Composition Trend (2014–2024)
This chart illustrates how Novolog Pharm-Up 1966 Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Novolog Pharm-Up 1966 Ltd's current assets represent 78.0% of total assets in 2024, a decrease from 95.1% in 2014.
- Cash Position: Cash and equivalents constituted 8.2% of total assets in 2024, up from 6.5% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 1.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 57.9% of total assets.
Novolog Pharm-Up 1966 Ltd Competitors by Total Assets
Key competitors of Novolog Pharm-Up 1966 Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
Novolog Pharm-Up 1966 Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Novolog Pharm-Up 1966 Ltd generates 0.67x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Novolog Pharm-Up 1966 Ltd generates $ 1.30 in net profit.
Novolog Pharm-Up 1966 Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.95 | 0.97 | 0.99 |
| Quick Ratio | 0.84 | 0.83 | 0.84 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA-133.02 Million | ILA -89.94 Million | ILA -25.64 Million |
Novolog Pharm-Up 1966 Ltd - Advanced Valuation Insights
This section examines the relationship between Novolog Pharm-Up 1966 Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.65 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 8.9% |
| Total Assets | ILA3.04 Billion |
| Market Capitalization | $1.62 Million USD |
Valuation Analysis
Below Book Valuation: The market values Novolog Pharm-Up 1966 Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Novolog Pharm-Up 1966 Ltd's assets grew by 8.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Novolog Pharm-Up 1966 Ltd (2014–2024)
The table below shows the annual total assets of Novolog Pharm-Up 1966 Ltd from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ILA3.04 Billion | +8.91% |
| 2023-12-31 | ILA2.79 Billion | +14.54% |
| 2022-12-31 | ILA2.43 Billion | +6.38% |
| 2021-12-31 | ILA2.29 Billion | +4.66% |
| 2020-12-31 | ILA2.19 Billion | +1.69% |
| 2019-12-31 | ILA2.15 Billion | +24.14% |
| 2018-12-31 | ILA1.73 Billion | -4.09% |
| 2017-12-31 | ILA1.81 Billion | +18.55% |
| 2016-12-31 | ILA1.52 Billion | -7.07% |
| 2015-12-31 | ILA1.64 Billion | +24.33% |
| 2014-12-31 | ILA1.32 Billion | -- |